Ruxolitinib as an Effective and Steroid-Sparing First-Line Treatment in Newly Diagnosed BOS Patients After Hematopoietic Stem Cell Transplantation

Bronchiolitis obliterans syndrome (BOS) is a life-threatening pulmonary complication of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). In this study, we retrospectively identified seven patients newly diagnosed with BOS post HSCT and analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoyu, Zhao, Xiaoli, Shen, Yuyan, Shi, Yuanyuan, Zhang, Lining, Hao, Mengze, Zhao, Fei, Zhang, Rongli, Wei, Jialin, Feng, Sizhou, He, Yi, Jiang, Erlie, Han, Mingzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294627/
https://www.ncbi.nlm.nih.gov/pubmed/35865938
http://dx.doi.org/10.3389/fphar.2022.916472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294627/
https://www.ncbi.nlm.nih.gov/pubmed/35865938
http://dx.doi.org/10.3389/fphar.2022.916472

Ejemplares similares